Ignite Creation Date:
2025-12-25 @ 12:43 AM
Ignite Modification Date:
2026-02-21 @ 11:18 PM
Study NCT ID:
NCT04758767
Status:
COMPLETED
Last Update Posted:
2025-04-03
First Post:
2021-02-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
CID-103 (Anti-CD38 Antibody) in Previously Treated Relapsed or Refractory Multiple Myeloma
Sponsor:
CASI Pharmaceuticals, Inc.
Organization: